SPANKA; Carsten
Patent Applications and Registrations
Patent applications and USPTO patent grants for SPANKA; Carsten.The latest application filed is for "naphthyridinedione derivatives".
- SPANKA; Carsten - Lorrach DE
- Spanka; Carsten - Basel N/A CH
- Spanka; Carsten - Loerrach DE
- Spanka; Carsten - Rheinfelden DE
| Patent | Date |
|---|---|
| Naphthyridinedione derivatives App 20190248784 - REINHARDT; Juergen ; et al. | 2019-08-15 |
| Naphthyridinedione derivatives Grant 10,138,232 - Reinhardt , et al. Nov | 2018-11-27 |
| Pyridopyrimidinedione derivatives Grant 9,884,862 - Schmiedeberg , et al. February 6, 2 | 2018-02-06 |
| Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones App 20170266189 - JACOBY; Edgar ; et al. | 2017-09-21 |
| Pyridopyrimidinedione derivatives App 20170197959 - REINHARDT; Juergen ; et al. | 2017-07-13 |
| Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones Grant 9,649,314 - Jacoby , et al. May 16, 2 | 2017-05-16 |
| Naphthyridinedione derivatives App 20150344476 - REINHARDT; Juergen ; et al. | 2015-12-03 |
| Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones App 20150335646 - JACOBY; Edgar ; et al. | 2015-11-26 |
| 3-Methyl-imidazo[1,2-b]pyridazine derivatives Grant 8,822,468 - Furet , et al. September 2, 2 | 2014-09-02 |
| Compounds and compositions as protein kinase inhibitors Grant 8,552,002 - Ding , et al. October 8, 2 | 2013-10-08 |
| Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands Grant 8,497,075 - Baumgarten , et al. July 30, 2 | 2013-07-30 |
| Compounds And Compositions As Protein Kinase Inhibitors App 20130012476 - DING; Qiang ; et al. | 2013-01-10 |
| Compounds And Compositions As Protein Kinase Inhibitors App 20130012704 - DING; Qiang ; et al. | 2013-01-10 |
| Organic Compounds App 20110243923 - Baumgarten; Birgit ; et al. | 2011-10-06 |
| Heterocyclic Compounds As Inhibitors Of Cxcr2 App 20110009429 - Oakley; Paul ; et al. | 2011-01-13 |
| Cxcr2 Inhibitors App 20100152205 - Hunt; Peter ; et al. | 2010-06-17 |
| CXCR2 inhibitors App 20100069407 - Press; Neil John ; et al. | 2010-03-18 |
| Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator Grant 7,625,950 - Hinterding , et al. December 1, 2 | 2009-12-01 |
| Novel Bi-aryl Amines App 20090286827 - Glatthar; Ralf ; et al. | 2009-11-19 |
| Amino-propanol derivatives Grant 7,612,238 - Buehlmayer , et al. November 3, 2 | 2009-11-03 |
| 3-methyl-imidazo[1,2-b]pyridazine Derivatives App 20090264406 - Furet; Pascal ; et al. | 2009-10-22 |
| Compounds and Compositions as Protein Kinase Inhibitors App 20090137804 - Ding; Qiang ; et al. | 2009-05-28 |
| Organic Compounds App 20090005363 - Glatthar; Ralf ; et al. | 2009-01-01 |
| Organic Compounds App 20080242698 - Flor; Peter Josef ; et al. | 2008-10-02 |
| Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator App 20060211658 - Hinterding; Klaus ; et al. | 2006-09-21 |
| Amino-propanol derivatives App 20060166940 - Buehlmayer; Peter ; et al. | 2006-07-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 